Bigul

Themis Medicare Ltd - 530199 - Board Meeting Intimation for Board Meeting Intimation For Consider Audited Financial Results And Recommending Dividend If Any On The Equity Shares Of The Company For The Financial Year 2020-21 On Thursday, 27.05.2021

THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve Please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Thursday, 27th May, 2021 inter alia, to transact the following business: 1.To consider the Audited Financial Results for the Quarter/Year ended on 31st March, 2021. 2.To consider recommending Dividend if any on the equity shares of the Company for the financial year 2020-21. Further, in continuation of our Letter dated 31st March 2021, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Thursday, 1st April, 2021, which shall remain closed till the closure of trading hours on 29th May, 2021 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results.
19-05-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement Under Regulation 30(LODR)- Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Themis Medicare Limited has submitted to BSE a copy of Clarification is enclosed.
12-05-2021
Bigul

Themis Medicare Ltd - 530199 - Clarification sought from Themis Medicare Ltd

The Exchange has sought clarification from Themis Medicare Ltd on May 10, 2021, with reference to Movement in Volume.The reply is awaited.
10-05-2021
Bigul

Themis Medicare Ltd - 530199 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayTHEMIS MEDICARE LTD. 2CINL24110GJ1969PLC001590 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 9.89 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: SANGAMESHWAR IYER Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: sangameshwar.iyer@themismedicare.com Name of the Chief Financial Officer: TUSHAR DALAL Designation: CHIEF FINANCIAL OFFICER EmailId: tushar.dalal@themismedicare.com Date: 30/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
30-04-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 31st March 2021.
26-04-2021
Bigul

Themis Medicare Ltd - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received the below mentioned intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from the following shareholder: Name Folio No. Cert. No. Number of Shares Dist. No. From Dist. No. To KIRAN CHANDRA KISHORE DAVE 00003855 5518 100 3267701 3267800
20-04-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2021 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company
20-04-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- sanagameshwar iyerDesignation :- Company Secretary and Compliance Officer
20-04-2021
Bigul

Themis Medicare Ltd - 530199 - Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended 31.03.2021

Enclosed herewith please find Compliance Certificate issued by M/s. V. Laxman & Co Practicing Company Secretaries for the half year ended 31st March, 2021 in terms of Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. This may be taken as compliance under Regulation 40(9) of the Listing Regulations.
20-04-2021
Bigul

Themis Medicare Ltd - 530199 - Shareholding for the Period Ended March 31, 2021

Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
19-04-2021
Next Page
Close

Let's Open Free Demat Account